Silvia Codenotti
Overview
Explore the profile of Silvia Codenotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pomella S, Porrazzo A, Cassandri M, Camero S, Codenotti S, Milazzo L, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362070
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood and adolescence that includes FP-RMS, harboring the fusion oncoprotein PAX3/7-FOXO1 and FN-RMS, often mutant in the RAS pathway. Risk...
12.
Camero S, Cassandri M, Pomella S, Milazzo L, Vulcano F, Porrazzo A, et al.
Front Oncol
. 2022 Oct;
12:1016894.
PMID: 36248991
Management of rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children, frequently accounting the genitourinary tract is complex and requires a multimodal therapy. In particular, as a consequence of...
13.
Codenotti S, Zizioli D, Mignani L, Rezzola S, Tabellini G, Parolini S, et al.
Cells
. 2022 Sep;
11(18).
PMID: 36139434
In pediatric rhabdomyosarcoma (RMS), elevated Akt signaling is associated with increased malignancy. Here, we report that expression of a constitutively active, myristoylated form of Akt1 (myrAkt1) in human RMS RD...
14.
Corsetti G, Romano C, Codenotti S, Pasini E, Fanzani A, Dioguardi F
Nutrients
. 2022 Jul;
14(14).
PMID: 35889872
Background: Excess body adipose tissue accumulation is a common and growing health problem caused by an unbalanced diet and/or junk food. Although the effects of dietary fat and glucose on...
15.
Cassandri M, Pomella S, Rossetti A, Petragnano F, Milazzo L, Vulcano F, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34639012
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood. About 25% of RMS expresses fusion oncoproteins such as PAX3/PAX7-FOXO1 (fusion-positive, FP) while fusion-negative (FN)-RMS harbors RAS mutations. Radiotherapy...
16.
Rossetti A, Petragnano F, Milazzo L, Vulcano F, Macioce G, Codenotti S, et al.
Int J Radiat Biol
. 2021 May;
97(7):943-957.
PMID: 33979259
Purpose: Herein we describe the in vitro and in vivo activity of FK228 (Romidepsin), an inhibitor of class I HDACs, in counteracting and radiosensitizing embryonal (ERMS, fusion-negative) and alveolar (ARMS,...
17.
Codenotti S, Marampon F, Triggiani L, Bonu M, Magrini S, Ceccaroli P, et al.
Cancer Lett
. 2021 Feb;
505:1-12.
PMID: 33610729
The aim of this work was to investigate whether Caveolin-1 (Cav-1), a membrane scaffolding protein widely implicated in cancer, may play a role in radiation response in rhabdomyosarcoma (RMS), a...
18.
Petragnano F, Pietrantoni I, Camero S, Codenotti S, Milazzo L, Vulcano F, et al.
J Biomed Sci
. 2020 Aug;
27(1):90.
PMID: 32854690
Background: The probability of local tumor control after radiotherapy (RT) remains still miserably poor in pediatric rhabdomyosarcoma (RMS). Thus, understanding the molecular mechanisms responsible of tumor relapse is essential to...
19.
Petragnano F, Pietrantoni I, Di Nisio V, Fasciani I, Del Fattore A, Capalbo C, et al.
Int J Radiat Biol
. 2020 Mar;
96(6):823-835.
PMID: 32149569
Radiation therapy (RT), by using ionizing radiation (IR), destroys cancer cells inducing DNA damage. Despite several studies are continuously performed to identify the best curative dose of IR, the role...
20.
Marampon F, Leoni F, Mancini A, Pietrantoni I, Codenotti S, Ferella L, et al.
J Cancer Res Clin Oncol
. 2019 Jul;
145(9):2411.
PMID: 31346710
In the original publication, the 6th author's first name and the last name was inverted and incorrectly published. The correct author name is Letizia Ferella.